Insulin glulisine is a rapid-acting insulin analog. It is currently manufactured by Sanofi Aventis under the brand name Apidra[1].
| Attributes | Values |
|---|---|
| rdfs:label |
|
| rdfs:comment |
|
| sameAs | |
| dcterms:subject | |
| onset |
|
| peaktime |
|
| dbkwik:diabetes/pr...iPageUsesTemplate | |
| Duration |
|
| abstract |
|